Robert Skinner
Concepts (422)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Cord | 34 | 2010 | 177 | 1.780 |
Why?
| Evoked Potentials, Auditory | 23 | 2010 | 101 | 1.350 |
Why?
| Fluorocarbons | 7 | 2019 | 45 | 1.270 |
Why?
| Mesencephalon | 22 | 2003 | 35 | 1.260 |
Why?
| Locomotion | 21 | 2001 | 92 | 1.070 |
Why?
| Reticular Formation | 16 | 2007 | 28 | 1.060 |
Why?
| Neuroprotective Agents | 7 | 2019 | 105 | 1.060 |
Why?
| Brain Stem | 17 | 2010 | 57 | 1.050 |
Why?
| Arousal | 12 | 2007 | 98 | 1.050 |
Why?
| Neurons | 29 | 2010 | 459 | 1.000 |
Why?
| Pons | 17 | 2002 | 33 | 0.920 |
Why?
| Motor Activity | 10 | 2004 | 230 | 0.910 |
Why?
| Stroke | 9 | 2020 | 492 | 0.770 |
Why?
| Animals | 103 | 2016 | 13150 | 0.660 |
Why?
| Electric Stimulation | 36 | 2010 | 116 | 0.650 |
Why?
| Rats | 59 | 2014 | 3300 | 0.620 |
Why?
| Spinal Cord Injuries | 8 | 2010 | 55 | 0.610 |
Why?
| Pedunculopontine Tegmental Nucleus | 10 | 2008 | 24 | 0.570 |
Why?
| Thrombolytic Therapy | 2 | 2015 | 111 | 0.560 |
Why?
| Brain Ischemia | 5 | 2020 | 161 | 0.550 |
Why?
| Posture | 3 | 2004 | 59 | 0.550 |
Why?
| Tissue Plasminogen Activator | 3 | 2015 | 110 | 0.520 |
Why?
| Infarction, Anterior Cerebral Artery | 1 | 2015 | 2 | 0.520 |
Why?
| Animals, Newborn | 13 | 2006 | 366 | 0.520 |
Why?
| Medulla Oblongata | 10 | 2005 | 21 | 0.510 |
Why?
| Infarction, Middle Cerebral Artery | 1 | 2015 | 40 | 0.500 |
Why?
| Fibrinolytic Agents | 2 | 2015 | 125 | 0.490 |
Why?
| H-Reflex | 9 | 2010 | 28 | 0.480 |
Why?
| Rats, Sprague-Dawley | 38 | 2014 | 1595 | 0.480 |
Why?
| Habituation, Psychophysiologic | 14 | 2011 | 33 | 0.430 |
Why?
| Cerebral Hemorrhage | 3 | 2015 | 104 | 0.400 |
Why?
| Cerebral Infarction | 2 | 2013 | 39 | 0.380 |
Why?
| Stress Disorders, Post-Traumatic | 5 | 2005 | 357 | 0.370 |
Why?
| Physical Conditioning, Animal | 4 | 2010 | 51 | 0.370 |
Why?
| Fetal Tissue Transplantation | 4 | 1999 | 10 | 0.360 |
Why?
| Locus Coeruleus | 4 | 2005 | 10 | 0.360 |
Why?
| Decerebrate State | 9 | 2004 | 13 | 0.350 |
Why?
| Electromyography | 19 | 2010 | 131 | 0.350 |
Why?
| Reaction Time | 14 | 2011 | 216 | 0.340 |
Why?
| Cats | 30 | 2004 | 79 | 0.340 |
Why?
| Disease Models, Animal | 10 | 2015 | 1451 | 0.330 |
Why?
| Respiration | 3 | 1994 | 96 | 0.310 |
Why?
| Schizophrenia | 5 | 2004 | 256 | 0.310 |
Why?
| Rabbits | 8 | 2016 | 370 | 0.310 |
Why?
| Emulsions | 4 | 2015 | 24 | 0.310 |
Why?
| Brain | 4 | 2016 | 1309 | 0.300 |
Why?
| Evoked Potentials, Auditory, Brain Stem | 4 | 2000 | 27 | 0.290 |
Why?
| Brain Damage, Chronic | 1 | 2006 | 14 | 0.280 |
Why?
| Time Factors | 16 | 2019 | 2912 | 0.280 |
Why?
| Neural Pathways | 15 | 2007 | 97 | 0.280 |
Why?
| Neural Inhibition | 4 | 2007 | 26 | 0.270 |
Why?
| Muscles | 6 | 1991 | 103 | 0.260 |
Why?
| Reflex, Abnormal | 4 | 2008 | 10 | 0.260 |
Why?
| Sleep, REM | 9 | 2007 | 44 | 0.260 |
Why?
| Tegmentum Mesencephali | 6 | 2004 | 8 | 0.250 |
Why?
| gamma-Aminobutyric Acid | 7 | 2007 | 64 | 0.250 |
Why?
| Hindlimb | 6 | 1999 | 30 | 0.250 |
Why?
| Benzhydryl Compounds | 3 | 2010 | 67 | 0.240 |
Why?
| Motor Neurons | 11 | 1997 | 39 | 0.240 |
Why?
| Electroencephalography | 9 | 2011 | 306 | 0.240 |
Why?
| Action Potentials | 18 | 2007 | 133 | 0.230 |
Why?
| Male | 42 | 2020 | 25093 | 0.230 |
Why?
| Female | 38 | 2020 | 26329 | 0.220 |
Why?
| Cerebellum | 4 | 1997 | 133 | 0.210 |
Why?
| Intercostal Muscles | 2 | 1992 | 6 | 0.210 |
Why?
| Sleep | 6 | 2005 | 182 | 0.200 |
Why?
| Levodopa | 3 | 2010 | 41 | 0.190 |
Why?
| Drug Administration Schedule | 3 | 2019 | 376 | 0.190 |
Why?
| Stilbamidines | 2 | 1990 | 2 | 0.190 |
Why?
| Random Allocation | 4 | 2015 | 280 | 0.190 |
Why?
| Analysis of Variance | 13 | 2011 | 565 | 0.190 |
Why?
| Efferent Pathways | 8 | 2004 | 13 | 0.190 |
Why?
| Acoustic Stimulation | 9 | 2005 | 97 | 0.180 |
Why?
| Thrombectomy | 1 | 2020 | 66 | 0.180 |
Why?
| Time-to-Treatment | 1 | 2020 | 62 | 0.180 |
Why?
| Attention | 2 | 2007 | 176 | 0.170 |
Why?
| Patient Transfer | 1 | 2020 | 95 | 0.170 |
Why?
| Narcolepsy | 2 | 1996 | 12 | 0.170 |
Why?
| Rape | 1 | 1999 | 14 | 0.160 |
Why?
| Cholinergic Fibers | 5 | 2005 | 8 | 0.160 |
Why?
| Afferent Pathways | 7 | 2010 | 12 | 0.160 |
Why?
| Acetylcholine | 4 | 2006 | 54 | 0.160 |
Why?
| Serotonin | 6 | 2003 | 151 | 0.160 |
Why?
| Synaptic Transmission | 5 | 2008 | 88 | 0.160 |
Why?
| Recovery of Function | 4 | 2019 | 189 | 0.150 |
Why?
| Cerebral Angiography | 3 | 2012 | 96 | 0.150 |
Why?
| Nerve Tissue | 1 | 1997 | 4 | 0.150 |
Why?
| NADPH Dehydrogenase | 8 | 1996 | 9 | 0.140 |
Why?
| Single-Blind Method | 1 | 2015 | 116 | 0.130 |
Why?
| Evoked Potentials, Somatosensory | 2 | 2011 | 11 | 0.130 |
Why?
| Drug Evaluation, Preclinical | 1 | 2015 | 144 | 0.120 |
Why?
| Infusions, Intravenous | 1 | 2015 | 207 | 0.120 |
Why?
| Evoked Potentials | 11 | 2007 | 69 | 0.120 |
Why?
| Reperfusion Injury | 1 | 2015 | 87 | 0.120 |
Why?
| Nicotine | 2 | 2006 | 186 | 0.120 |
Why?
| Electrophysiology | 9 | 2007 | 78 | 0.120 |
Why?
| Neurotransmitter Agents | 2 | 1991 | 34 | 0.120 |
Why?
| Intracranial Embolism | 2 | 2012 | 27 | 0.120 |
Why?
| Cell Count | 5 | 2005 | 146 | 0.120 |
Why?
| Circadian Rhythm | 1 | 1994 | 87 | 0.110 |
Why?
| Muscle Tonus | 2 | 2001 | 22 | 0.110 |
Why?
| Adrenergic alpha-Agonists | 2 | 2006 | 20 | 0.110 |
Why?
| Humans | 26 | 2020 | 49827 | 0.110 |
Why?
| Clonidine | 2 | 2006 | 26 | 0.110 |
Why?
| Vestibular Nuclei | 3 | 1984 | 9 | 0.110 |
Why?
| Middle Aged | 13 | 2020 | 11997 | 0.110 |
Why?
| West Nile virus | 2 | 2010 | 4 | 0.110 |
Why?
| Receptors, Serotonin | 4 | 2003 | 29 | 0.110 |
Why?
| Rats, Inbred Strains | 6 | 1991 | 196 | 0.100 |
Why?
| Smoking | 2 | 2007 | 510 | 0.100 |
Why?
| Auditory Perception | 2 | 2004 | 29 | 0.100 |
Why?
| Combat Disorders | 2 | 2005 | 37 | 0.100 |
Why?
| Gap Junctions | 2 | 2008 | 26 | 0.100 |
Why?
| Substance P | 2 | 1991 | 27 | 0.100 |
Why?
| Microbubbles | 1 | 2011 | 25 | 0.100 |
Why?
| Thalamus | 1 | 1991 | 36 | 0.100 |
Why?
| Ultrasonic Therapy | 1 | 2011 | 32 | 0.100 |
Why?
| Parasympathomimetics | 2 | 1990 | 15 | 0.100 |
Why?
| Pregnancy | 7 | 2007 | 2584 | 0.100 |
Why?
| Schizophrenic Psychology | 1 | 1991 | 68 | 0.090 |
Why?
| Aspartic Acid | 2 | 1990 | 49 | 0.090 |
Why?
| Reflex, Stretch | 1 | 2010 | 5 | 0.090 |
Why?
| Muscle Spasticity | 1 | 2010 | 9 | 0.090 |
Why?
| Cold Temperature | 1 | 2011 | 44 | 0.090 |
Why?
| West Nile Fever | 1 | 2010 | 3 | 0.090 |
Why?
| Fluorescent Dyes | 6 | 1990 | 101 | 0.090 |
Why?
| Dopamine Agents | 1 | 2010 | 17 | 0.090 |
Why?
| Brain Chemistry | 3 | 2007 | 70 | 0.090 |
Why?
| Diaphragm | 1 | 2010 | 29 | 0.090 |
Why?
| Dose-Response Relationship, Drug | 7 | 2016 | 1374 | 0.090 |
Why?
| Dihydrolipoamide Dehydrogenase | 1 | 1989 | 2 | 0.080 |
Why?
| Motor Neuron Disease | 1 | 2009 | 5 | 0.080 |
Why?
| Proprioception | 1 | 1989 | 6 | 0.080 |
Why?
| Receptors, Muscarinic | 2 | 2006 | 19 | 0.080 |
Why?
| Carbenoxolone | 1 | 2008 | 4 | 0.080 |
Why?
| Mefloquine | 1 | 2008 | 4 | 0.080 |
Why?
| Cervical Vertebrae | 2 | 2010 | 59 | 0.080 |
Why?
| Histocytochemistry | 5 | 1996 | 44 | 0.080 |
Why?
| Immunohistochemistry | 6 | 2010 | 971 | 0.080 |
Why?
| Brain Mapping | 9 | 1997 | 234 | 0.080 |
Why?
| Magnetic Resonance Imaging | 1 | 2014 | 1533 | 0.070 |
Why?
| Veterans | 3 | 2005 | 550 | 0.070 |
Why?
| Exercise Therapy | 1 | 2008 | 98 | 0.070 |
Why?
| Aging | 6 | 2007 | 688 | 0.070 |
Why?
| Psychoneuroimmunology | 1 | 2006 | 2 | 0.070 |
Why?
| Nerve Regeneration | 2 | 1997 | 24 | 0.070 |
Why?
| Encephalomyelitis | 1 | 2006 | 6 | 0.070 |
Why?
| Free Radicals | 1 | 2006 | 28 | 0.070 |
Why?
| Sick Role | 1 | 2006 | 14 | 0.070 |
Why?
| Receptors, Nicotinic | 1 | 2006 | 76 | 0.070 |
Why?
| Chemokines | 1 | 2006 | 77 | 0.070 |
Why?
| Synapses | 3 | 1984 | 87 | 0.070 |
Why?
| Central Nervous System Stimulants | 1 | 2008 | 213 | 0.070 |
Why?
| Axons | 6 | 1997 | 46 | 0.070 |
Why?
| Adult | 9 | 2020 | 13160 | 0.070 |
Why?
| Acupuncture Points | 1 | 2005 | 2 | 0.070 |
Why?
| Membrane Potentials | 5 | 2007 | 117 | 0.070 |
Why?
| Aged | 7 | 2020 | 9272 | 0.070 |
Why?
| Cell Death | 1 | 2006 | 181 | 0.070 |
Why?
| Parkinson Disease | 2 | 1998 | 152 | 0.060 |
Why?
| N-Methylaspartate | 3 | 1996 | 27 | 0.060 |
Why?
| Long-Term Potentiation | 1 | 2005 | 31 | 0.060 |
Why?
| Americas | 1 | 2005 | 2 | 0.060 |
Why?
| Postmortem Changes | 1 | 2005 | 14 | 0.060 |
Why?
| Physical Education and Training | 1 | 2005 | 24 | 0.060 |
Why?
| Trigeminal Nuclei | 1 | 1984 | 5 | 0.060 |
Why?
| Dopamine | 4 | 2010 | 171 | 0.060 |
Why?
| Bicycling | 1 | 2005 | 24 | 0.060 |
Why?
| Motor Vehicles | 1 | 2005 | 15 | 0.060 |
Why?
| Microglia | 1 | 2006 | 141 | 0.060 |
Why?
| Body Temperature Regulation | 2 | 1997 | 24 | 0.060 |
Why?
| Low Back Pain | 1 | 2004 | 26 | 0.060 |
Why?
| Connexins | 3 | 2008 | 25 | 0.060 |
Why?
| Muscimol | 2 | 2007 | 3 | 0.060 |
Why?
| GABA Agonists | 2 | 2007 | 15 | 0.060 |
Why?
| Avidin | 1 | 2004 | 8 | 0.060 |
Why?
| Excitatory Amino Acid Antagonists | 2 | 2002 | 50 | 0.060 |
Why?
| Sleep Stages | 2 | 2003 | 45 | 0.060 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2006 | 181 | 0.060 |
Why?
| Anesthetics, Intravenous | 1 | 2003 | 24 | 0.060 |
Why?
| Huntington Disease | 1 | 2003 | 23 | 0.060 |
Why?
| Propofol | 1 | 2003 | 22 | 0.060 |
Why?
| Cytokines | 1 | 2006 | 612 | 0.060 |
Why?
| Choline O-Acetyltransferase | 3 | 1991 | 5 | 0.050 |
Why?
| Auditory Cortex | 3 | 1999 | 22 | 0.050 |
Why?
| Alzheimer Disease | 2 | 1996 | 317 | 0.050 |
Why?
| Gas Chromatography-Mass Spectrometry | 2 | 2016 | 67 | 0.050 |
Why?
| Globus Pallidus | 2 | 1998 | 8 | 0.050 |
Why?
| Sodium Channel Blockers | 3 | 2007 | 13 | 0.050 |
Why?
| Neurons, Afferent | 2 | 1999 | 30 | 0.050 |
Why?
| Case-Control Studies | 3 | 2003 | 1128 | 0.050 |
Why?
| Reflex, Monosynaptic | 3 | 1980 | 6 | 0.050 |
Why?
| Spinal Nerve Roots | 2 | 1991 | 14 | 0.050 |
Why?
| Denervation | 2 | 1991 | 20 | 0.050 |
Why?
| Muscle Contraction | 3 | 1991 | 103 | 0.050 |
Why?
| Ibogaine | 1 | 2000 | 1 | 0.050 |
Why?
| GABA Antagonists | 3 | 1990 | 11 | 0.050 |
Why?
| Mechanoreceptors | 1 | 1980 | 8 | 0.050 |
Why?
| Restraint, Physical | 1 | 2000 | 20 | 0.050 |
Why?
| Chick Embryo | 2 | 1997 | 83 | 0.050 |
Why?
| Tetrodotoxin | 3 | 2006 | 10 | 0.050 |
Why?
| Triage | 1 | 2020 | 64 | 0.040 |
Why?
| Dopamine Uptake Inhibitors | 1 | 2000 | 55 | 0.040 |
Why?
| Pyrimidines | 3 | 2006 | 191 | 0.040 |
Why?
| Muscle, Skeletal | 2 | 2010 | 750 | 0.040 |
Why?
| Vestibular Nerve | 1 | 1979 | 6 | 0.040 |
Why?
| Receptors, N-Methyl-D-Aspartate | 3 | 2003 | 126 | 0.040 |
Why?
| Maximum Tolerated Dose | 1 | 2019 | 37 | 0.040 |
Why?
| Tibial Nerve | 1 | 1979 | 6 | 0.040 |
Why?
| Cricetinae | 2 | 2010 | 192 | 0.040 |
Why?
| Sciatic Nerve | 1 | 1979 | 26 | 0.040 |
Why?
| Neuromuscular Blocking Agents | 1 | 1999 | 7 | 0.040 |
Why?
| Administration, Intravenous | 1 | 2019 | 68 | 0.040 |
Why?
| Cerebral Cortex | 1 | 2000 | 200 | 0.040 |
Why?
| Cocaine | 1 | 2000 | 169 | 0.040 |
Why?
| Auditory Pathways | 1 | 1999 | 6 | 0.040 |
Why?
| Auditory Threshold | 2 | 2000 | 49 | 0.040 |
Why?
| Disability Evaluation | 1 | 2019 | 87 | 0.040 |
Why?
| Anesthetics | 1 | 1999 | 37 | 0.040 |
Why?
| Astrocytes | 2 | 1997 | 145 | 0.040 |
Why?
| Crime Victims | 1 | 1999 | 33 | 0.040 |
Why?
| Stress, Psychological | 1 | 2000 | 260 | 0.040 |
Why?
| Yohimbine | 3 | 2006 | 10 | 0.040 |
Why?
| Adrenergic alpha-Antagonists | 3 | 2006 | 27 | 0.040 |
Why?
| Horseradish Peroxidase | 3 | 1990 | 16 | 0.040 |
Why?
| Olivary Nucleus | 1 | 1997 | 6 | 0.040 |
Why?
| Double-Blind Method | 1 | 2019 | 674 | 0.040 |
Why?
| Glutamates | 1 | 2016 | 21 | 0.040 |
Why?
| Injections, Intravenous | 1 | 2016 | 140 | 0.040 |
Why?
| Tissue Distribution | 1 | 2016 | 164 | 0.040 |
Why?
| Presynaptic Terminals | 1 | 1996 | 15 | 0.030 |
Why?
| Cohort Studies | 1 | 2020 | 1422 | 0.030 |
Why?
| Interleukin-1 | 1 | 1996 | 104 | 0.030 |
Why?
| Ethanol | 1 | 1999 | 338 | 0.030 |
Why?
| Angiography | 1 | 2016 | 126 | 0.030 |
Why?
| Tyrosine 3-Monooxygenase | 2 | 1996 | 11 | 0.030 |
Why?
| Nicotinic Agonists | 2 | 2006 | 55 | 0.030 |
Why?
| Alcoholism | 1 | 1999 | 232 | 0.030 |
Why?
| Lumbosacral Region | 3 | 1992 | 12 | 0.030 |
Why?
| Nicotinic Antagonists | 2 | 2006 | 46 | 0.030 |
Why?
| Substantia Nigra | 3 | 1984 | 14 | 0.030 |
Why?
| NADP | 2 | 2006 | 22 | 0.030 |
Why?
| Chronic Disease | 2 | 2010 | 563 | 0.030 |
Why?
| Body Weight | 2 | 2006 | 513 | 0.030 |
Why?
| Down-Regulation | 2 | 2008 | 349 | 0.030 |
Why?
| Treatment Outcome | 2 | 2019 | 5138 | 0.030 |
Why?
| Follow-Up Studies | 1 | 2020 | 2179 | 0.030 |
Why?
| Physical Stimulation | 2 | 2008 | 35 | 0.030 |
Why?
| Stereotyped Behavior | 1 | 1995 | 17 | 0.030 |
Why?
| Peripheral Nerves | 3 | 2004 | 51 | 0.030 |
Why?
| Brain Infarction | 1 | 2014 | 12 | 0.030 |
Why?
| Anxiety Disorders | 1 | 1995 | 126 | 0.030 |
Why?
| Muscarinic Antagonists | 2 | 2006 | 21 | 0.030 |
Why?
| Cardiovascular Agents | 2 | 2006 | 54 | 0.030 |
Why?
| Organ Culture Techniques | 2 | 2006 | 50 | 0.030 |
Why?
| Methamphetamine | 1 | 1997 | 200 | 0.030 |
Why?
| Carotid Artery, Common | 1 | 2014 | 44 | 0.030 |
Why?
| Prospective Studies | 1 | 2020 | 2344 | 0.030 |
Why?
| Middle Cerebral Artery | 1 | 2014 | 35 | 0.030 |
Why?
| Sudden Infant Death | 1 | 1994 | 14 | 0.030 |
Why?
| Anesthetics, Local | 2 | 2006 | 75 | 0.030 |
Why?
| Image Processing, Computer-Assisted | 2 | 1995 | 241 | 0.030 |
Why?
| Arkansas | 1 | 2019 | 1967 | 0.030 |
Why?
| Wakefulness | 3 | 2000 | 53 | 0.030 |
Why?
| Picrotoxin | 2 | 1990 | 5 | 0.030 |
Why?
| Bicuculline | 2 | 1990 | 5 | 0.030 |
Why?
| Neural Conduction | 2 | 1983 | 34 | 0.030 |
Why?
| Severity of Illness Index | 2 | 2010 | 942 | 0.030 |
Why?
| Rotation | 2 | 2002 | 45 | 0.030 |
Why?
| Carbachol | 2 | 2002 | 27 | 0.020 |
Why?
| Movement | 2 | 2003 | 82 | 0.020 |
Why?
| Hydrogen-Ion Concentration | 1 | 1992 | 174 | 0.020 |
Why?
| Foot | 2 | 2011 | 43 | 0.020 |
Why?
| Fibroblast Growth Factor 2 | 1 | 1991 | 34 | 0.020 |
Why?
| Statistics, Nonparametric | 1 | 2011 | 197 | 0.020 |
Why?
| Thorax | 1 | 1991 | 15 | 0.020 |
Why?
| Culture Techniques | 1 | 1991 | 20 | 0.020 |
Why?
| Neck | 1 | 1992 | 99 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2011 | 282 | 0.020 |
Why?
| Rhodamines | 1 | 1990 | 5 | 0.020 |
Why?
| Pyramidal Tracts | 1 | 1990 | 5 | 0.020 |
Why?
| Torque | 1 | 2010 | 18 | 0.020 |
Why?
| Mesocricetus | 1 | 2010 | 6 | 0.020 |
Why?
| Cell Size | 2 | 2004 | 45 | 0.020 |
Why?
| Physical Therapy Modalities | 1 | 2010 | 34 | 0.020 |
Why?
| Microscopy, Confocal | 1 | 2010 | 87 | 0.020 |
Why?
| Computer Simulation | 1 | 1991 | 282 | 0.020 |
Why?
| Septal Nuclei | 1 | 1989 | 5 | 0.020 |
Why?
| NADH, NADPH Oxidoreductases | 1 | 1989 | 12 | 0.020 |
Why?
| Neurophysiology | 2 | 2008 | 9 | 0.020 |
Why?
| Oculomotor Nerve | 2 | 1980 | 4 | 0.020 |
Why?
| Microinjections | 2 | 2000 | 29 | 0.020 |
Why?
| Ultrasonography | 1 | 2011 | 436 | 0.020 |
Why?
| Electrophysiological Phenomena | 1 | 2009 | 18 | 0.020 |
Why?
| Serotonin Receptor Agonists | 2 | 2000 | 14 | 0.020 |
Why?
| Viral Envelope Proteins | 1 | 2009 | 30 | 0.020 |
Why?
| Biophysical Phenomena | 1 | 2008 | 19 | 0.020 |
Why?
| Cell Membrane | 2 | 2003 | 248 | 0.020 |
Why?
| Antigens, Viral | 1 | 2009 | 44 | 0.020 |
Why?
| Injections | 1 | 2008 | 55 | 0.020 |
Why?
| Radiography | 1 | 2010 | 489 | 0.020 |
Why?
| Serotonin Antagonists | 2 | 2000 | 34 | 0.020 |
Why?
| Blood Pressure | 1 | 1991 | 514 | 0.020 |
Why?
| Age Factors | 2 | 2004 | 1090 | 0.020 |
Why?
| Retrospective Studies | 1 | 2020 | 6117 | 0.020 |
Why?
| RNA, Viral | 1 | 2009 | 125 | 0.020 |
Why?
| Rats, Wistar | 1 | 2008 | 223 | 0.020 |
Why?
| Thoracic Vertebrae | 1 | 2008 | 36 | 0.020 |
Why?
| Hippocampus | 1 | 1989 | 228 | 0.020 |
Why?
| Bisbenzimidazole | 1 | 1987 | 1 | 0.020 |
Why?
| Receptors, Cholinergic | 1 | 1987 | 14 | 0.020 |
Why?
| GABA-B Receptor Antagonists | 1 | 2007 | 4 | 0.020 |
Why?
| Baclofen | 1 | 2007 | 9 | 0.020 |
Why?
| Receptors, GABA-B | 1 | 2007 | 11 | 0.020 |
Why?
| Muscarinic Agonists | 1 | 2006 | 10 | 0.020 |
Why?
| S100 Proteins | 2 | 1997 | 34 | 0.020 |
Why?
| Pregnancy Rate | 1 | 2006 | 2 | 0.020 |
Why?
| Fetal Viability | 1 | 2006 | 2 | 0.020 |
Why?
| Biotin | 1 | 2006 | 45 | 0.020 |
Why?
| Exercise | 1 | 2010 | 490 | 0.020 |
Why?
| Carbon Monoxide | 1 | 2006 | 40 | 0.020 |
Why?
| Child | 2 | 2000 | 6824 | 0.020 |
Why?
| Blotting, Western | 2 | 1997 | 602 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2008 | 904 | 0.020 |
Why?
| Disease Progression | 1 | 2008 | 822 | 0.020 |
Why?
| Infant | 1 | 1994 | 3551 | 0.020 |
Why?
| Anti-Anxiety Agents | 1 | 2005 | 35 | 0.020 |
Why?
| Quadriplegia | 1 | 2005 | 9 | 0.020 |
Why?
| Adolescent | 2 | 2011 | 6340 | 0.020 |
Why?
| Xanthenes | 1 | 2004 | 7 | 0.010 |
Why?
| Fluoresceins | 1 | 2004 | 11 | 0.010 |
Why?
| Cells, Cultured | 2 | 2003 | 1571 | 0.010 |
Why?
| Dose-Response Relationship, Radiation | 1 | 2004 | 184 | 0.010 |
Why?
| Receptors, Kainic Acid | 1 | 2003 | 8 | 0.010 |
Why?
| Cell Differentiation | 1 | 2006 | 653 | 0.010 |
Why?
| Pain Measurement | 1 | 2004 | 236 | 0.010 |
Why?
| Antidepressive Agents | 1 | 2004 | 176 | 0.010 |
Why?
| Kynurenic Acid | 1 | 2002 | 3 | 0.010 |
Why?
| Cholinergic Agonists | 1 | 2002 | 10 | 0.010 |
Why?
| Motion Sickness | 1 | 2002 | 8 | 0.010 |
Why?
| Models, Animal | 1 | 2003 | 233 | 0.010 |
Why?
| Vestibule, Labyrinth | 1 | 2002 | 16 | 0.010 |
Why?
| Sural Nerve | 2 | 1979 | 8 | 0.010 |
Why?
| Nausea | 1 | 2002 | 51 | 0.010 |
Why?
| Young Adult | 1 | 2011 | 3936 | 0.010 |
Why?
| Vestibulocochlear Nerve | 1 | 1980 | 4 | 0.010 |
Why?
| Forelimb | 1 | 1980 | 3 | 0.010 |
Why?
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2000 | 8 | 0.010 |
Why?
| Corticotropin-Releasing Hormone | 1 | 2000 | 14 | 0.010 |
Why?
| Hydroxyindoleacetic Acid | 1 | 2000 | 8 | 0.010 |
Why?
| Receptors, Adrenergic, alpha-2 | 1 | 2000 | 7 | 0.010 |
Why?
| Homovanillic Acid | 1 | 2000 | 10 | 0.010 |
Why?
| Joints | 1 | 1980 | 18 | 0.010 |
Why?
| Nervous System Physiological Phenomena | 2 | 1970 | 9 | 0.010 |
Why?
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 2000 | 1 | 0.010 |
Why?
| Receptors, Serotonin, 5-HT1 | 1 | 2000 | 2 | 0.010 |
Why?
| Pindolol | 1 | 2000 | 4 | 0.010 |
Why?
| Interneurons | 2 | 1970 | 31 | 0.010 |
Why?
| Macaca fascicularis | 1 | 1979 | 10 | 0.010 |
Why?
| Haplorhini | 1 | 1979 | 24 | 0.010 |
Why?
| Drug Interactions | 1 | 2000 | 206 | 0.010 |
Why?
| Nerve Fibers | 1 | 1979 | 9 | 0.010 |
Why?
| Depression | 1 | 2004 | 564 | 0.010 |
Why?
| Nerve Crush | 1 | 1979 | 2 | 0.010 |
Why?
| Myosins | 1 | 1999 | 17 | 0.010 |
Why?
| Myosin Heavy Chains | 1 | 1999 | 20 | 0.010 |
Why?
| Species Specificity | 1 | 1979 | 193 | 0.010 |
Why?
| Halothane | 1 | 1999 | 3 | 0.010 |
Why?
| Neck Muscles | 1 | 1999 | 5 | 0.010 |
Why?
| Pentobarbital | 1 | 1999 | 28 | 0.010 |
Why?
| Drug Combinations | 1 | 1999 | 123 | 0.010 |
Why?
| Abducens Nerve | 1 | 1978 | 1 | 0.010 |
Why?
| Ketamine | 1 | 1999 | 60 | 0.010 |
Why?
| Eye Movements | 1 | 1978 | 26 | 0.010 |
Why?
| Craniocerebral Trauma | 1 | 1999 | 68 | 0.010 |
Why?
| Neurons, Efferent | 1 | 1997 | 3 | 0.010 |
Why?
| Purkinje Cells | 1 | 1997 | 15 | 0.010 |
Why?
| Glial Fibrillary Acidic Protein | 1 | 1997 | 30 | 0.010 |
Why?
| Metergoline | 1 | 1997 | 2 | 0.010 |
Why?
| Sex Factors | 1 | 2000 | 693 | 0.010 |
Why?
| Skin | 1 | 1980 | 407 | 0.010 |
Why?
| Tail | 1 | 1997 | 10 | 0.010 |
Why?
| Prostaglandins | 1 | 1997 | 20 | 0.010 |
Why?
| Dopamine Antagonists | 1 | 1997 | 20 | 0.010 |
Why?
| Indomethacin | 1 | 1997 | 38 | 0.010 |
Why?
| Psychotropic Drugs | 1 | 1997 | 77 | 0.010 |
Why?
| Body Temperature | 1 | 1997 | 69 | 0.010 |
Why?
| Vietnam | 1 | 1997 | 21 | 0.010 |
Why?
| Haloperidol | 1 | 1997 | 46 | 0.010 |
Why?
| Cyclooxygenase Inhibitors | 1 | 1997 | 39 | 0.010 |
Why?
| Amyloid beta-Peptides | 1 | 1997 | 69 | 0.010 |
Why?
| Neurosurgical Procedures | 1 | 1998 | 121 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1996 | 65 | 0.010 |
Why?
| Blotting, Northern | 1 | 1996 | 109 | 0.010 |
Why?
| Amyloid beta-Protein Precursor | 1 | 1996 | 23 | 0.010 |
Why?
| Patch-Clamp Techniques | 1 | 1996 | 124 | 0.010 |
Why?
| Computers | 3 | 1973 | 47 | 0.010 |
Why?
| Glioma | 1 | 1996 | 79 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 1996 | 465 | 0.010 |
Why?
| Neuropsychological Tests | 1 | 1997 | 351 | 0.010 |
Why?
| Exploratory Behavior | 1 | 1995 | 23 | 0.010 |
Why?
| Recruitment, Neurophysiological | 1 | 1974 | 2 | 0.010 |
Why?
| Up-Regulation | 1 | 1996 | 450 | 0.010 |
Why?
| Brain Neoplasms | 1 | 1996 | 286 | 0.010 |
Why?
| Cross-Sectional Studies | 1 | 1997 | 1541 | 0.010 |
Why?
| Embryo, Mammalian | 1 | 1991 | 65 | 0.010 |
Why?
| Computers, Analog | 1 | 1970 | 1 | 0.010 |
Why?
| Aged, 80 and over | 1 | 1997 | 3125 | 0.010 |
Why?
| Gestational Age | 1 | 1991 | 417 | 0.010 |
Why?
| Cell Survival | 1 | 1991 | 598 | 0.010 |
Why?
| Ganglia, Spinal | 1 | 1967 | 49 | 0.000 |
Why?
| Antibodies, Monoclonal | 1 | 1991 | 458 | 0.000 |
Why?
| Immunoenzyme Techniques | 1 | 1987 | 143 | 0.000 |
Why?
| Models, Neurological | 1 | 1985 | 57 | 0.000 |
Why?
| Thalamic Nuclei | 1 | 1983 | 8 | 0.000 |
Why?
| Amygdala | 1 | 1983 | 36 | 0.000 |
Why?
| Staining and Labeling | 1 | 1983 | 97 | 0.000 |
Why?
| Analog-Digital Conversion | 1 | 1973 | 3 | 0.000 |
Why?
| Peroneal Nerve | 1 | 1973 | 6 | 0.000 |
Why?
| Spinal Nerves | 1 | 1973 | 10 | 0.000 |
Why?
| Microelectrodes | 1 | 1973 | 22 | 0.000 |
Why?
| Leg | 1 | 1973 | 122 | 0.000 |
Why?
|
|
Skinner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|